| A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease EMK Warlo, H Arnesen, I Seljeflot Thrombosis Journal 17, 1-9, 2019 | 71 | 2019 |
| vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease EMK Warlo, AÅR Pettersen, H Arnesen, I Seljeflot Thrombosis Journal 15, 1-8, 2017 | 15 | 2017 |
| ADAMTS13 regulation of von Willebrand factor in cardiovascular diseases EMK Warlo | | 2024 |
| von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction EMK Warlo, AA Kalstad, PL Myhre, S Solheim, H Arnesen, A Tveit, ... Research and Practice in Thrombosis and Haemostasis 7 (4), 100164, 2023 | | 2023 |
| Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events EMK Warlo, V Bratseth, AÅR Pettersen, PA Holme, H Arnesen, I Seljeflot, ... Clinical and Applied Thrombosis/Hemostasis 28, 10760296221141893, 2022 | | 2022 |
| Oral Presentation No. 32 The interplay between VWF, ADAMTS13 and TSP1, and their relation to clinical endpoints EMK Warlo, AA Kalstad, PL Myhre, S Solheim, H Arnesen, A Tveit, ... Cardiovascular Research 118 (Supplement_2), cvac157. 003, 2022 | | 2022 |
| A brief review on resistance to P2Y12 receptor antagonism in coronary artery EMK Warlo, H Arnesen, I Seljeflot | | 2019 |
| Implementering av sjekkliste for trakeotomi ved intensivavdelingen på Rikshospitalet KM Gundersen, B Heide, JB Hjukse, M Hjorth-Johansen, HM Rosseland, ... | | 2019 |
